T. Rowe Price Associates »

Puma Biotechnology shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Puma Biotechnology (PBYI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Puma Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Puma Biotechnology held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Puma Biotechnology by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2013-03-31 $33M 981k 33.39
2012-12-31 $18M 983k 18.75

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Tesla Comm Stk (TSLA)
Broadcom Comm Stk (AVGO)
Unitedhealth Group Comm Stk (UNH)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Servicenow Comm Stk (NOW)

View all positions for T. Rowe Price Associates

Top funds holding Puma Biotechnology

Acorn Capital Advisors
Vanguard Group
BlackRock
Renaissance Technologies
Acadian Asset Management
American Century Companies
Dimensional Fund Advisors
Geode Capital Management
Russell Investments
Connor, Clark & Lunn Investment Management
Kennedy Capital Management
O'shaughnessy Asset Management
State Street Corporation
Comprehensive Portfolio Management
Marshall Wace

View all funds holding Puma Biotechnology